tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
CHRS is currently covered by 3 analysts with an average price target of $10.75. This is a potential upside of $9.4 (696.3%) from yesterday's end of day stock price of $1.35.
Coherus BioSciences's activity chart (see below) currently has 136 price targets and 100 ratings on display. The stock rating distribution of CHRS is 80% BUY and 20% HOLD.
Analysts average stock forecasts to be materialized ratio is 12.22% with an average time for these price targets to be met of 81.2 days.
Highest price target for CHRS is $4, Lowest price target is $1.05, average price target is $2.53.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 04-Sep-2025. First documented stock forecast 20-Jan-2016.
Currently out of the existing stock ratings of CHRS, 4 are a BUY (80%), 1 are a HOLD (20%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$4
$2.64 (194.12%)
3 months 8 days ago
(04-Sep-2025)
3/9 (33.33%)
$2.69 (205.34%)
181
Buy
7 months 13 days ago
(29-Apr-2025)
0/14 (0%)
$5.29 (309.36%)
Hold
$1.05
$-0.31 (-22.79%)
$1.5
7 months 18 days ago
(24-Apr-2025)
2/4 (50%)
$0.04 (3.96%)
58
Buy
$7
$5.64 (414.71%)
$7
1 years 6 months 29 days ago
(13-May-2024)
0/5 (0%)
$4.91 (234.93%)
Buy
$11
$9.64 (708.82%)
1 years 8 months 22 days ago
(20-Mar-2024)
0/4 (0%)
$8.52 (343.55%)
What is CHRS (Coherus BioSciences) average time for price targets to be met?
Which analyst has the current highest performing score on CHRS (Coherus BioSciences) with a proven track record?
Which analyst has the most public recommendations on CHRS (Coherus BioSciences)?
Which analyst is the currently most bullish on CHRS (Coherus BioSciences)?
Which analyst is the currently most reserved on CHRS (Coherus BioSciences)?
